The End of AIDS?: An Introduction

Optimism about a cure for HIV/AIDS is the highest it's been since David Ho pioneered the Highly Active Antiretroviral Treatment (HAART) drug cocktail in 1996.  Just last week, the powerful antiretroviral drug Truvada was shown to be effective not only as treatment but also as prophylaxis: among participants who used the drug daily, there was a 90 percent reduction in infection, roughly comparable to using a condom. 

In light of this exciting news, Big Think spoke with some of the world's leading AIDS researchers, physicians, and activists about the state of the epidemic and the ongoing search for a cure. This three-day series will highlight the cutting-edge scientific research, examine the dangers of stigma, and investigate the political and economic challenges of battling HIV/AIDS globally and domestically.

During the first day of the series, we take a look at the most promising avenues of HIV/AIDS research. Some scientists still believe it is possible to eradicate every last particle of virus from the body. But many now imagine that a cure will be a so-called "functional cure," which will lower the virus to undetectable levels either by boosting the immune system or through gene therapy. This is what seems to have occurred in the body of the "Berlin patient," an HIV-positive man who received genetically-mutated bone marrow transplants to treat his leukemia. Most scientists agree that he is the first man to be cured of HIV. This and other recent successes build upon previous decades of tremendous scientific research, including David Ho's groundbreaking discovery of HAART. Ho explains to Big Think how this drug cocktail works and tells us about the "eureka moment" that led to this discovery. 

The second day of the series addresses the devastating stigma attached to the disease, featuring discussions with two of the most prominent public figures living with HIV: Andrew Sullivan, the Atlantic's political commentator and blogger, and Regan Hofmann, the editor-in-chief of POZ magazine. Dr. Paul Bellman, a major voice in HIV/AIDS clinical care, also explains that current antiretroviral treatment is so effective that it renders people virtually unable to transmit the disease, information which he hopes will help combat the stigma. 

The final day of the series examines the policy and economics of HIV/AIDS treatment and prevention domestically and globally. Seth Berkley, founder of the International AIDS Vaccine Initiative, explains the economics of creating an AIDS vaccine and discusses strategies to incentivize innovation. But given the efficacy of modern antiretroviral treatment, some argue that it may be possible to halt the AIDS epidemic in Africa through aggressive and widespread treatment, rather than searching for a "silver bullet" cure. And though over 80 percent of those living with HIV are in Africa, the epidemic is on the rise in the United States as well. But the Obama Administration has made a real commitment to combating it, says Marjorie Hill, CEO of Gay Men's Health Crisis, the world's oldest AIDS non-profit. For creating the first National AIDS Strategy in U.S. history, Obama deserves an A minus, she say. The media, however, does not rate so well. "If I were going to give the media at large a grade on HIV coverage, it would be a D minus," she says. "And the only reason why is isn’t an 'F' is because of World Aids Day." 

This series is our attempt to bring public awareness to this ongoing epidemic; it is still a major public health crisis, but we are closer to a cure than ever before. 

LinkedIn meets Tinder in this mindful networking app

Swipe right to make the connections that could change your career.

Getty Images
Swipe right. Match. Meet over coffee or set up a call.

No, we aren't talking about Tinder. Introducing Shapr, a free app that helps people with synergistic professional goals and skill sets easily meet and collaborate.

Keep reading Show less

Space toilets: How astronauts boldly go where few have gone before

A NASA astronomer explains how astronauts dispose of their, uh, dark matter.

  • When nature calls in micro-gravity, astronauts must answer. Space agencies have developed suction-based toilets – with a camera built in to ensure all the waste is contained before "flushing".
  • Yes, there have been floaters in space. The early days of space exploration were a learning curve!
  • Amazingly, you don't need gravity to digest food. Peristalsis, the process by which your throat and intestines squeeze themselves, actually moves food and water through your digestive system without gravity at all.
Keep reading Show less

Steven Pinker's 13 rules for writing better

The Harvard psychologist loves reading authors' rules for writing. Here are his own.

NEW YORK, NY - JULY 21: Steven Pinker speaks onstage during OZY Fest 2018 at Rumsey Playfield, Central Park on July 21, 2018 in New York City. (Photo by Brad Barket/Getty Images for Ozy Media)
Personal Growth
  • Steven Pinker is many things: linguist, psychologist, optimist, Harvard professor, and author.
  • When it comes to writing, he's a student and a teacher.
  • Here's are his 13 rules for writing better, more simply, and more clearly.
Keep reading Show less

Can the keto diet help treat depression? Here’s what the science says so far

A growing body of research shows promising signs that the keto diet might be able to improve mental health.

Public Domain
Mind & Brain
  • The keto diet is known to be an effective tool for weight loss, however its effects on mental health remain largely unclear.
  • Recent studies suggests that the keto diet might be an effective tool for treating depression, and clearing up so-called "brain fog," though scientists caution more research is necessary before it can be recommended as a treatment.
  • Any experiments with the keto diet are best done in conjunction with a doctor, considering some people face problems when transitioning to the low-carb diet.
Keep reading Show less